NCT00335881已完成4 期
Multicentre Study to Assess Persistence of Antibodies Against Hepatitis B & Immune Response to a Hepatitis B Challenge Dose in Healthy Children 4 to 6 Years Old Previously Vaccinated With 4 Doses of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 300
- 试验地点
- 39
- 主要终点
- Anti-HBs antibody concentration
研究概览
简要总结
Persistence of seroprotective antibody concentrations & immunological memory shown by the ability to mount a response to a challenge dose of HBV vaccine
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 4 Years 至 6 Years（Child）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •A male or female aged 4 to 6 years at the time of study entry .
- •Subjects who have received a total of 4 doses of DTPa-HBV-IPV/Hib vaccine in previous vaccination studies.
- •Evidence of previous hepatitis B booster vaccination or disease since administration of the fourth dose of DTPa-HBV-IPV/Hib vaccine.
排除标准
- 未提供
结局指标
主要结局
Anti-HBs antibody concentration
次要结局
- Persistence of antibodies to the other DTPa-HBV-IPV/Hib vaccine antigens.
- Sol & unsol symptoms after HBV vaccination, SAEs
研究者
研究点 (39)
Loading locations...
相似试验
已完成
4 期
Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/HibHepatitis BNCT00356564GlaxoSmithKline350
已完成
3 期
Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean InfantsPoliomyelitisHepatitis BDiphtheriaTetanusPertussisNCT00303316Sanofi458
已完成
2 期
A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects.Haemophilus Influenzae Type bWhole Cell PertussisHepatitis BTetanusDiphtheriaNCT00317174GlaxoSmithKline450
撤回
3 期
Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary StudyInfections, PapillomavirusNCT02100618GlaxoSmithKline
已完成
不适用
Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up StudyMeningococcal InfectionsMeningococcal MeningitisNCT02500511JN-International Medical Corporation50